• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

标准早餐对环丙沙星药物吸收及多剂量药代动力学的影响。

Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.

作者信息

Ledergerber B, Bettex J D, Joos B, Flepp M, Lüthy R

出版信息

Antimicrob Agents Chemother. 1985 Mar;27(3):350-2. doi: 10.1128/AAC.27.3.350.

DOI:10.1128/AAC.27.3.350
PMID:3158273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC176275/
Abstract

Ciprofloxacin was administered to 10 volunteers, who received seven oral doses of 250 mg each at 12-h intervals. Volunteers alternately fasted (F) or received a standard breakfast (B) before the morning dose. Pharmacokinetic parameters were derived from high-pressure liquid chromatography data from samples taken after the first and seventh doses and were analyzed in addition for differences caused by food intake. A significant (P less than 0.05) influence of the standard breakfast on the time to the peak was observed. Peak levels (+/- standard deviation) after the first and seventh doses averaged F (fasting): 1.35 +/- 0.17, B (breakfast): 1.02 +/- 0.28 micrograms/ml, and F: 1.41 +/- 0.32, B: 1.17 +/- 0.5 micrograms/ml, respectively. Mean trough concentrations after the first and seventh doses were F: 0.10 +/- 0.03, B: 0.14 +/- 0.03 micrograms/ml, and F: 0.16 +/- 0.05, B: 0.14 +/- 0.04 microgram/ml, respectively. As with the peak, trough concentrations were not affected significantly by food intake or by accumulation over the study period. Breakfast equally did not affect the terminal half-lives, which averaged F: 3.97 +/- 0.67, B: 4.35 +/- 0.88 h after the first dose and F: 4.64 +/- 0.91, B: 3.72 +/- 0.84 h after the seventh dose. Twelve-hour urinary recovery measured by high-pressure liquid chromatography averaged F: 31, B: 30% for the first dose and, in spite of a possible carry-over from the sixth dose, decreased to F: 25, B: 28% after the seventh dosing interval. When measured by bioassay, an increase of urinary recovery between the first dose (F: 38, B: 38%) and the seventh dose (F: 45, B: 45%) was observed. These differences suggest induction of drug metabolism with repeated doses. Ciprofloxacin was well tolerated by the volunteers.

摘要

给10名志愿者服用环丙沙星,他们每隔12小时口服7次,每次250毫克。志愿者在早晨服药前交替禁食(F)或食用标准早餐(B)。药代动力学参数来自首次和第七次给药后采集样本的高压液相色谱数据,并分析了食物摄入造成的差异。观察到标准早餐对达峰时间有显著影响(P小于0.05)。首次和第七次给药后的峰浓度(±标准差)平均为:禁食(F)时,1.35±0.17;早餐(B)时,1.02±0.28微克/毫升,以及首次给药后禁食时1.41±0.32,早餐时1.17±0.5微克/毫升。首次和第七次给药后的平均谷浓度分别为:禁食时0.10±0.03,早餐时0.14±0.03微克/毫升,以及首次给药后禁食时0.16±0.05,早餐时0.14±0.04微克/毫升。与峰浓度一样,谷浓度不受食物摄入或研究期间蓄积的显著影响。早餐同样不影响终末半衰期,首次给药后平均禁食时为:3.97±0.67小时,早餐时为4.35±0.88小时;第七次给药后禁食时为4.64±0.91小时,早餐时为3.72±0.84小时。通过高压液相色谱法测得的12小时尿回收率,首次给药时平均禁食为31%,早餐为30%,尽管可能存在第六次给药的残留影响,但在第七次给药间隔后降至禁食时25%,早餐时28%。通过生物测定法测量时,观察到首次给药(禁食时38%,早餐时38%)和第七次给药(禁食时45%,早餐时45%)之间尿回收率有所增加。这些差异表明重复给药会诱导药物代谢。志愿者对环丙沙星耐受性良好。

相似文献

1
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin.标准早餐对环丙沙星药物吸收及多剂量药代动力学的影响。
Antimicrob Agents Chemother. 1985 Mar;27(3):350-2. doi: 10.1128/AAC.27.3.350.
2
Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration.口服和静脉注射后环丙沙星在健康志愿者体内的药代动力学。
Eur J Clin Microbiol. 1986 Apr;5(2):179-86. doi: 10.1007/BF02013983.
3
Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.环丙沙星在正常志愿者中的多剂量药代动力学及安全性
Antimicrob Agents Chemother. 1984 Nov;26(5):741-4. doi: 10.1128/AAC.26.5.741.
4
Pharmacokinetics of oral ciprofloxacin, 100 mg single dose, in volunteers and elderly patients.
J Antimicrob Chemother. 1986 May;17(5):629-35. doi: 10.1093/jac/17.5.629.
5
Single-dose pharmacokinetics of oral ciprofloxacin in patients with cystic fibrosis.囊性纤维化患者口服环丙沙星的单剂量药代动力学
J Clin Pharmacol. 1986 Mar;26(3):222-6. doi: 10.1002/j.1552-4604.1986.tb02938.x.
6
Pharmacokinetics of ciprofloxacin after intravenous and increasing oral doses.
Eur J Clin Microbiol. 1986 Apr;5(2):187-92. doi: 10.1007/BF02013984.
7
Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses.环丙沙星序贯递增口服剂量后的药代动力学及耐受性
Antimicrob Agents Chemother. 1986 Jan;29(1):62-6. doi: 10.1128/AAC.29.1.62.
8
Multiple-dose ciprofloxacin dose ranging and kinetics.
Clin Pharmacol Ther. 1985 Jun;37(6):633-7. doi: 10.1038/clpt.1985.102.
9
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
10
Single and multiple dose pharmacokinetics of ciprofloxacin.
Eur J Clin Microbiol. 1986 Apr;5(2):193-6. doi: 10.1007/BF02013985.

引用本文的文献

1
Together or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses.联合或分开?揭示饮食干预对喹诺酮类药物生物利用度的影响:系统评价与荟萃分析。
Clin Pharmacokinet. 2024 Jun;63(6):773-818. doi: 10.1007/s40262-024-01377-0. Epub 2024 May 28.
2
Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.金黄色葡萄球菌菌血症中早期口服抗生素转换:金黄色葡萄球菌网络适应平台(SNAP)试验早期口服转换方案。
Clin Infect Dis. 2024 Oct 15;79(4):871-887. doi: 10.1093/cid/ciad666.
3
Genome-wide association study to identify SNPs and candidate genes associated with body size traits in donkeys.全基因组关联研究以鉴定与驴体型性状相关的单核苷酸多态性和候选基因。
Front Genet. 2023 Feb 28;14:1112377. doi: 10.3389/fgene.2023.1112377. eCollection 2023.
4
Pharmacokinetics and Tissue Residue Profiles of Enrofloxacin in Crucian Carp () Following Single and Multiple Oral Administration.恩诺沙星在鲫鱼单次和多次口服给药后的药代动力学及组织残留特征
Front Vet Sci. 2022 Apr 14;9:872828. doi: 10.3389/fvets.2022.872828. eCollection 2022.
5
Building in-house PBPK modelling tools for oral drug administration from literature information.利用文献信息构建用于口服给药的内部生理药代动力学(PBPK)建模工具。
ADMET DMPK. 2019 Feb 23;7(1):4-21. doi: 10.5599/admet.638. eCollection 2019.
6
Effects of ABCB1, UGT1A1, and UGT1A9 Genetic Polymorphisms on the Pharmacokinetics of Sitafloxacin Granules in Healthy Subjects.ABCB1、UGT1A1 和 UGT1A9 基因多态性对健康受试者西他沙星颗粒药代动力学的影响。
Clin Pharmacol Drug Dev. 2021 Jan;10(1):57-67. doi: 10.1002/cpdd.848. Epub 2020 Jul 20.
7
A Physiologically-Based Pharmacokinetic Model to Describe Ciprofloxacin Pharmacokinetics Over the Entire Span of Life.一个描述环丙沙星药代动力学在整个生命周期内的生理基于药代动力学模型。
Clin Pharmacokinet. 2018 Dec;57(12):1613-1634. doi: 10.1007/s40262-018-0661-6.
8
Food-drug interactions.食物-药物相互作用
Drugs. 2002;62(10):1481-502. doi: 10.2165/00003495-200262100-00005.
9
Effect of food on the pharmacokinetics of a single oral dose of moxifloxacin 400mg in healthy male volunteers.食物对健康男性志愿者单次口服400mg莫西沙星药代动力学的影响。
Clin Pharmacokinet. 2001;40 Suppl 1:19-25. doi: 10.2165/00003088-200140001-00003.
10
Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.新型氟喹诺酮类抗菌药物的比较药代动力学与药效学
Clin Pharmacokinet. 2001;40(3):169-87. doi: 10.2165/00003088-200140030-00003.

本文引用的文献

1
Pharmacokinetics and tissue penetration of ciprofloxacin.环丙沙星的药代动力学及组织穿透性
Antimicrob Agents Chemother. 1983 Nov;24(5):784-6. doi: 10.1128/AAC.24.5.784.
2
Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.环丙沙星、诺氟沙星、恶喹酸、西诺沙星和萘啶酸的抗菌活性。
Antimicrob Agents Chemother. 1984 May;25(5):633-7. doi: 10.1128/AAC.25.5.633.
3
In vitro activity of ciprofloxacin (Bay o 9867).环丙沙星(拜耳o 9867)的体外活性。
Antimicrob Agents Chemother. 1983 Oct;24(4):568-74. doi: 10.1128/AAC.24.4.568.
4
In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.新型喹啉衍生物Bay 09867与其他抗菌药物的体外活性比较。
Antimicrob Agents Chemother. 1983 Apr;23(4):559-64. doi: 10.1128/AAC.23.4.559.
5
Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine.高压液相色谱法与生物测定法测定血清和尿液中环丙沙星的比较。
Antimicrob Agents Chemother. 1985 Mar;27(3):353-6. doi: 10.1128/AAC.27.3.353.
6
Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.线性药代动力学方程允许根据已拟合数据的多指数方程的系数和指数直接计算许多所需的药代动力学参数。
J Pharmacokinet Biopharm. 1976 Oct;4(5):443-67. doi: 10.1007/BF01062831.
7
CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.CSTRIP,一个用于获取初始多指数参数估计值的Fortran IV计算机程序。
J Pharm Sci. 1976 Jul;65(7):1006-10. doi: 10.1002/jps.2600650713.